TECH

58.63

0.17% -0.10

Dopo l'orario di chiusura: 58.63

Bio Techne Corp (TECH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$58.73

Aprire:

$57.98

Volume 24 ore:

1.47M

Relative Volume:

1.03

Capitalizzazione di mercato:

$9.65B

Reddito:

$1.17B

Utile/perdita netta:

$150.71M

Rapporto P/E:

62.37

EPS:

0.94

Flusso di cassa netto:

$245.03M

1 W Prestazione:

-4.00%

1M Prestazione:

-5.05%

6M Prestazione:

-26.65%

1 anno Prestazione:

-16.71%

Intervallo 1D:

$56.70

$59.20

Intervallo di 1 settimana:

$56.70

$61.86

Portata 52W:

$56.60

$85.57

Bio Techne Corp Stock (TECH) Company Profile

Nome

Bio Techne Corp

Settore

Healthcare (1164)

Industria

Biotechnology (681)

Telefono

(612) 379-8854

Indirizzo

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Dipendente

Cinguettio

@biotechne

Prossima data di guadagno

2024-10-30

Ultimi documenti SEC

TECH's Discussions on Twitter

Confronta TECH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TECH Bio Techne Corp	58.63	9.65B	1.17B	150.71M	245.03M	0.94
VRTX Vertex Pharmaceuticals Inc	484.82	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	634.23	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.87	36.10B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	270.02	35.03B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	272.17	28.24B	3.81B	-644.79M	-669.77M	-6.24

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-18	Iniziato	Evercore ISI	Outperform
2025-02-19	Downgrade	Robert W. Baird	Outperform → Neutral
2024-05-22	Downgrade	Citigroup	Buy → Neutral
2024-02-08	Iniziato	Scotiabank	Sector Outperform
2024-02-02	Downgrade	Stifel	Buy → Hold
2023-12-07	Iniziato	UBS	Buy
2023-08-28	Iniziato	William Blair	Outperform
2023-01-10	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2022-12-14	Iniziato	Deutsche Bank	Buy
2022-12-12	Aggiornamento	Citigroup	Neutral → Buy
2022-12-07	Iniziato	RBC Capital Mkts	Sector Perform
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-04-25	Downgrade	Wells Fargo	Equal Weight → Underweight
2021-09-15	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-08	Aggiornamento	Stephens	Equal-Weight → Overweight
2021-02-23	Aggiornamento	Stifel	Hold → Buy
2021-01-25	Reiterato	The Benchmark Company	Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-07-15	Downgrade	Stephens	Overweight → Equal-Weight
2020-05-27	Downgrade	Stifel	Buy → Hold
2020-05-14	Iniziato	The Benchmark Company	Buy
2020-01-08	Ripresa	Stephens	Overweight
2020-01-08	Iniziato	Wells Fargo	Equal Weight
2020-01-07	Iniziato	Citigroup	Neutral
2019-11-15	Iniziato	Stifel	Buy
2019-07-02	Aggiornamento	Janney	Neutral → Buy
2019-01-14	Aggiornamento	Stephens	Equal-Weight → Overweight
2018-10-31	Downgrade	Craig Hallum	Buy → Hold
2018-10-17	Iniziato	Goldman	Neutral
2018-06-15	Iniziato	Argus	Buy
2017-07-13	Iniziato	Wells Fargo	Market Perform
2017-02-09	Iniziato	Citigroup	Buy
2017-01-18	Iniziato	Deutsche Bank	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-01-21	Reiterato	Robert W. Baird	Outperform
2013-09-20	Aggiornamento	Robert W. Baird	Neutral → Outperform

Mostra tutto

Bio Techne Corp Borsa (TECH) Ultime notizie

10:00 AM

Bio-Techne Opens New Customer Experience Centre in Germany - Yahoo Finance

10:00 AM

05:12 AM

3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Yahoo Finance

05:12 AM

Mar 28, 2025

Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch - Yahoo Finance

Mar 28, 2025

Mar 26, 2025

Bio-Techne to Open New Customer Facility in Germany - Marketscreener.com

Mar 26, 2025

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany - Yahoo Finance

Mar 26, 2025

Mar 24, 2025

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Quantisnow

Mar 24, 2025

Game-Changing Cancer Detection Technology: RNAscope Shows Superior Results in Multiple Tumors - Stock Titan

Mar 24, 2025

Mar 19, 2025

Bio-Techne Earnings Preview: What to Expect - MSN

Mar 19, 2025

Evercore ISI Group Initiates Coverage of Bio-Techne (TECH) with Outperform Recommendation - MSN

Mar 19, 2025

Mar 18, 2025

Evercore ISI sets Bio-Techne stock Outperform with $75 target By Investing.com - Investing.com South Africa

Mar 18, 2025

6 Analysts Assess Bio-Techne: What You Need To Know - Benzinga

Mar 18, 2025

Evercore ISI sets Bio-Techne stock Outperform with $75 target - Investing.com

Mar 18, 2025

Mar 17, 2025

Bio-Techne: A Premium Growth Asset with Strong Market Position and Promising Future - TipRanks

Mar 17, 2025

Bio-Techne (NASDAQ:TECH) shareholders have earned a 8.3% CAGR over the last five years - Yahoo Finance

Mar 17, 2025

Mar 13, 2025

Bio-Techne Co. (NASDAQ:TECH) Receives $82.14 Consensus Price Target from Analysts - Defense World

Mar 13, 2025

Mar 12, 2025

Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.

Mar 12, 2025

Bio Techne at Barclays Conference: Strategic Growth Amid Market Challenges - Investing.com

Mar 12, 2025

TECH Stock Might Rise Following the Leo Shipping Announcement - Nasdaq

Mar 12, 2025

Mar 11, 2025

Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch

Mar 11, 2025

Bio-Techne at Leerink’s Global Healthcare Conference: Strategic Growth Amid Challenges - Investing.com India

Mar 11, 2025

Techne Corp stock hits 52-week low at $58.94 amid market shifts - Investing.com India

Mar 11, 2025

Techne Corp stock hits 52-week low at $58.94 amid market shifts By Investing.com - Investing.com South Africa

Mar 11, 2025

GC Wealth Management RIA LLC Takes $805,000 Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Mar 11, 2025

Mar 10, 2025